Á lódáil...
Sitagliptin and oral cancer risk in type 2 diabetes patients
The reimbursement database of the Taiwan’s National Health Insurance was used to evaluate oral cancer risk after sitagliptin use. Patients newly diagnosed of type 2 diabetes during 1999–2008 were recruited. A 1:1 propensity score matched-pair sample of 39195 ever users and 39195 never users were fol...
Na minha lista:
| Foilsithe in: | Oncotarget |
|---|---|
| Príomhúdar: | |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Impact Journals LLC
2017
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722520/ https://ncbi.nlm.nih.gov/pubmed/29228568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18239 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|